Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy
Clinical trial NCT07209332 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07209332
- Sponsor
- Wave Life Sciences USA, Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-28
- Primary completion
- 2029-03-01
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.